Skip to main content
SpringerLink
Log in

Polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) in ovarian cancer risk

  • Research Article
  • Published:
Tumor Biology

Abstract

Glutathione S-transferases (GSTs) are ubiquitous, multifunctional phase II metabolic enzymes responsible for the detoxification of estrogen involved in the development of ovarian cancer. Data from epidemiological studies show conflicting results that remain to be further clarified. We estimated in this study the genetic effects of GSTM1 and GSTT1 polymorphisms on ovarian cancer risk. Eligible studies of the two polymorphisms and ovarian cancer risk were identified from China National Knowledge Infrastructure (CNKI), PubMed, Embase, and Web of Science. We summarized all data and performed a meta-analysis. Odds ratio (OR) and 95 % CI was calculated by using the fixed effects model to estimate the associations. Eight eligible studies were finally identified providing 2,397 cases and 2,910 controls for GSTM1 polymorphism and 2,049 cases and 2,668 controls for GSTT1 polymorphism. The overall data showed that carries of the GSTM1 null genotype did not have significantly increased ovarian cancer risk compared with those who carried the GSTM1 present genotype (null vs. present—OR, 1.01; 95 % CI, 0.91–1.11; heterogeneity, P = 0.672). Similarly, for GSTT1 polymorphism, we observed no association under the investigated model in the overall analysis (null vs. present—OR, 1.02; 95 % CI, 0.89–1.17; heterogeneity, P = 0.372), and in the subgroup of Caucasian subjects (null vs. present—OR, 0.99; 95 % CI, 0.86–1.14; heterogeneity, P = 0.959). The meta-analysis does not provide a strong evidence for causal associations between GSTM1 and GSTT1 polymorphisms and risk of ovarian cancer in Caucasians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jemal A et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  2. Colombo N et al. Ovarian cancer. Crit Rev Oncol Hematol. 2006;60(2):159–79.

    Article  PubMed  Google Scholar 

  3. Shih Ie M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164(5):1511–8.

    Article  PubMed  Google Scholar 

  4. Bell DA. Origins and molecular pathology of ovarian cancer. Mod Pathol. 2005;18 Suppl 2:S19–32.

    Article  CAS  PubMed  Google Scholar 

  5. Roy D et al. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev. 2007;10(4):235–57.

    Article  CAS  PubMed  Google Scholar 

  6. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51–88.

    Article  CAS  PubMed  Google Scholar 

  7. Garte S et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10(12):1239–48.

    CAS  PubMed  Google Scholar 

  8. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett. 2005;221(2):123–9.

    Article  CAS  PubMed  Google Scholar 

  9. Clapper ML. Genetic polymorphism and cancer risk. Curr Oncol Rep. 2000;2(3):251–6.

    Article  CAS  PubMed  Google Scholar 

  10. Knudsen LE, Loft SH, Autrup H. Risk assessment: the importance of genetic polymorphisms in man. Mutat Res. 2001;482(1–2):83–8.

    Article  CAS  PubMed  Google Scholar 

  11. Oliveira C et al. Polymorphisms of glutathione S-transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) genes and epithelial ovarian cancer risk. Dis Markers. 2012;33(3):155–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Spurdle AB et al. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis. 2001;22(1):67–72.

    Article  CAS  PubMed  Google Scholar 

  13. Baxter SW, Thomas EJ, Campbell IG. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis. 2001;22(1):63–5.

    Article  CAS  PubMed  Google Scholar 

  14. Goodman JE et al. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2000;9(12):1373–6.

    CAS  PubMed  Google Scholar 

  15. Lallas TA et al. The glutathione S-transferase M1 genotype in ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2000;9(6):587–90.

    CAS  PubMed  Google Scholar 

  16. Higgins JP et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

    CAS  PubMed  Google Scholar 

  19. Egger M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Gates MA et al. Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2436–44.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Hengstler JG et al. Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Lett. 1998;130(1–2):43–8.

    Article  CAS  PubMed  Google Scholar 

  22. Sarhanis P et al. Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression. Br J Cancer. 1996;74(11):1757–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Chunhua Z. Clinic research for gene polymorphism of GSTTI and susceptibility of ovarian cancer [article in Chinese]. China: Jilin University; 2008.

    Google Scholar 

  24. Mannervik B et al. Nomenclature for human glutathione transferases. Biochem J. 1992;282(Pt 1):305–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Chasseaud LF. The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res. 1979;29:175–274.

    Article  CAS  PubMed  Google Scholar 

  26. Pearson WR et al. Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet. 1993;53(1):220–33.

    PubMed Central  CAS  PubMed  Google Scholar 

  27. Webb G et al. Chromosomal localization of the gene for the human theta class glutathione transferase (GSTT1). Genomics. 1996;33(1):121–3.

    Article  CAS  PubMed  Google Scholar 

  28. Brockmoller J et al. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res. 1993;53(5):1004–11.

    CAS  PubMed  Google Scholar 

  29. Zhong S et al. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 1993;14(9):1821–4.

    Article  CAS  PubMed  Google Scholar 

  30. Van Hemelrijck M et al. Heterocyclic aromatic amine [HCA] intake and prostate cancer risk: effect modification by genetic variants. Nutr Cancer. 2012;64(5):704–13.

    Article  PubMed  Google Scholar 

  31. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1997;6(9):733–43.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Beijing Friendship Hospital, Capital Medical University, Yong’an Road, Xuanwu District, Beijing, 100050, China

    Ying Jin & Zengping Hao

Authors
  1. Ying Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zengping Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zengping Hao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jin, Y., Hao, Z. Polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) in ovarian cancer risk. Tumor Biol. 35, 5267–5272 (2014). https://doi.org/10.1007/s13277-014-1685-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1685-7

Keywords

Search

Navigation